APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Research

General Medicines Industry Research Report 2026

29 December 2025147 pages

Choose your research edition.

Industry ResearchGeneral Medicines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal General Medicines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal General Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Medicines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal General Medicines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global General Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for General Medicines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for General Medicines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of General Medicines include Sun Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global General Medicines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

General Medicines Market by Company

Sun Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Jiangsu Hengrui Medicine

Bayer

Amgen

AbbVie

AstraZeneca

Zoetis

Vertex Pharmaceuticals

Takeda Pharmaceutical

Seagen

Regeneron Pharmaceuticals

Novo Nordisk

Moderna

Lonza

Horizon Therapeutics

GlaxoSmithKline

Gilead Sciences

Daiichi Sankyō

CVS Health

Chugai Pharmaceutical

Bristol-Myers Squibb

Biogen

Argenx

General Medicines Segment by Type

Over-the-Counter (OTC)

Prescription (Rx)

General Medicines Segment by Application

Antihypertensives

Antibiotics

Antidiabetic Drugs

Antipyretics

Analgesics

Others

General Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of General Medicines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of General Medicines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of General Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global General Medicines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global General Medicines Sales (K Units) of Manufacturers (2021-2026) Table 7. Global General Medicines Sales Market Share by Manufacturers (2021-2026) Table 8. Global General Medicines Revenue of Manufacturers (2021-2026) Table 9. Global General Medicines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market General Medicines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global General Medicines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of General Medicines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of General Medicines, Product Type & Application Table 14. Global General Medicines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global General Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sun Pharmaceutical Company Information Table 19. Sun Pharmaceutical Business Overview Table 20. Sun Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sun Pharmaceutical General Medicines Product Portfolio Table 22. Sun Pharmaceutical Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sanofi General Medicines Product Portfolio Table 27. Sanofi Recent Developments Table 28. Johnson & Johnson Company Information Table 29. Johnson & Johnson Business Overview Table 30. Johnson & Johnson General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Johnson & Johnson General Medicines Product Portfolio Table 32. Johnson & Johnson Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Novartis General Medicines Product Portfolio Table 37. Novartis Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck General Medicines Product Portfolio Table 42. Merck Recent Developments Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Roche General Medicines Product Portfolio Table 47. Roche Recent Developments Table 48. Eli Lilly Company Information Table 49. Eli Lilly Business Overview Table 50. Eli Lilly General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Eli Lilly General Medicines Product Portfolio Table 52. Eli Lilly Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer General Medicines Product Portfolio Table 57. Pfizer Recent Developments Table 58. Jiangsu Hengrui Medicine Company Information Table 59. Jiangsu Hengrui Medicine Business Overview Table 60. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jiangsu Hengrui Medicine General Medicines Product Portfolio Table 62. Jiangsu Hengrui Medicine Recent Developments Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer General Medicines Product Portfolio Table 67. Bayer Recent Developments Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amgen General Medicines Product Portfolio Table 72. Amgen Recent Developments Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AbbVie General Medicines Product Portfolio Table 77. AbbVie Recent Developments Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AstraZeneca General Medicines Product Portfolio Table 82. AstraZeneca Recent Developments Table 83. Zoetis Company Information Table 84. Zoetis Business Overview Table 85. Zoetis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zoetis General Medicines Product Portfolio Table 87. Zoetis Recent Developments Table 88. Vertex Pharmaceuticals Company Information Table 89. Vertex Pharmaceuticals Business Overview Table 90. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Vertex Pharmaceuticals General Medicines Product Portfolio Table 92. Vertex Pharmaceuticals Recent Developments Table 93. Takeda Pharmaceutical Company Information Table 94. Takeda Pharmaceutical Business Overview Table 95. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Takeda Pharmaceutical General Medicines Product Portfolio Table 97. Takeda Pharmaceutical Recent Developments Table 98. Seagen Company Information Table 99. Seagen Business Overview Table 100. Seagen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Seagen General Medicines Product Portfolio Table 102. Seagen Recent Developments Table 103. Regeneron Pharmaceuticals Company Information Table 104. Regeneron Pharmaceuticals Business Overview Table 105. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Regeneron Pharmaceuticals General Medicines Product Portfolio Table 107. Regeneron Pharmaceuticals Recent Developments Table 108. Novo Nordisk Company Information Table 109. Novo Nordisk Business Overview Table 110. Novo Nordisk General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Novo Nordisk General Medicines Product Portfolio Table 112. Novo Nordisk Recent Developments Table 113. Moderna Company Information Table 114. Moderna Business Overview Table 115. Moderna General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Moderna General Medicines Product Portfolio Table 117. Moderna Recent Developments Table 118. Lonza Company Information Table 119. Lonza Business Overview Table 120. Lonza General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Lonza General Medicines Product Portfolio Table 122. Lonza Recent Developments Table 123. Horizon Therapeutics Company Information Table 124. Horizon Therapeutics Business Overview Table 125. Horizon Therapeutics General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Horizon Therapeutics General Medicines Product Portfolio Table 127. Horizon Therapeutics Recent Developments Table 128. GlaxoSmithKline Company Information Table 129. GlaxoSmithKline Business Overview Table 130. GlaxoSmithKline General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. GlaxoSmithKline General Medicines Product Portfolio Table 132. GlaxoSmithKline Recent Developments Table 133. Gilead Sciences Company Information Table 134. Gilead Sciences Business Overview Table 135. Gilead Sciences General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Gilead Sciences General Medicines Product Portfolio Table 137. Gilead Sciences Recent Developments Table 138. Daiichi Sankyō Company Information Table 139. Daiichi Sankyō Business Overview Table 140. Daiichi Sankyō General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Daiichi Sankyō General Medicines Product Portfolio Table 142. Daiichi Sankyō Recent Developments Table 143. CVS Health Company Information Table 144. CVS Health Business Overview Table 145. CVS Health General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. CVS Health General Medicines Product Portfolio Table 147. CVS Health Recent Developments Table 148. Chugai Pharmaceutical Company Information Table 149. Chugai Pharmaceutical Business Overview Table 150. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Chugai Pharmaceutical General Medicines Product Portfolio Table 152. Chugai Pharmaceutical Recent Developments Table 153. Bristol-Myers Squibb Company Information Table 154. Bristol-Myers Squibb Business Overview Table 155. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Bristol-Myers Squibb General Medicines Product Portfolio Table 157. Bristol-Myers Squibb Recent Developments Table 158. Biogen Company Information Table 159. Biogen Business Overview Table 160. Biogen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Biogen General Medicines Product Portfolio Table 162. Biogen Recent Developments Table 163. Argenx Company Information Table 164. Argenx Business Overview Table 165. Argenx General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Argenx General Medicines Product Portfolio Table 167. Argenx Recent Developments Table 168. Global General Medicines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 169. Global General Medicines Sales by Region (2021-2026) & (K Units) Table 170. Global General Medicines Sales Market Share by Region (2021-2026) Table 171. Global General Medicines Sales by Region (2027-2032) & (K Units) Table 172. Global General Medicines Sales Market Share by Region (2027-2032) Table 173. Global General Medicines Revenue by Region (2021-2026) & (US$ Million) Table 174. Global General Medicines Revenue Market Share by Region (2021-2026) Table 175. Global General Medicines Revenue by Region (2027-2032) & (US$ Million) Table 176. Global General Medicines Revenue Market Share by Region (2027-2032) Table 177. North America General Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. North America General Medicines Sales by Country (2021-2026) & (K Units) Table 179. North America General Medicines Sales by Country (2027-2032) & (K Units) Table 180. North America General Medicines Revenue by Country (2021-2026) & (US$ Million) Table 181. North America General Medicines Revenue by Country (2027-2032) & (US$ Million) Table 182. Europe General Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 184. Europe General Medicines Sales by Country (2027-2032) & (K Units) Table 185. Europe General Medicines Revenue by Country (2021-2026) & (US$ Million) Table 186. Europe General Medicines Revenue by Country (2027-2032) & (US$ Million) Table 187. Asia Pacific General Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. Asia Pacific General Medicines Sales by Country (2021-2026) & (K Units) Table 189. Asia Pacific General Medicines Sales by Country (2027-2032) & (K Units) Table 190. Asia Pacific General Medicines Revenue by Country (2021-2026) & (US$ Million) Table 191. Asia Pacific General Medicines Revenue by Country (2027-2032) & (US$ Million) Table 192. South America General Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 193. South America General Medicines Sales by Country (2021-2026) & (K Units) Table 194. South America General Medicines Sales by Country (2027-2032) & (K Units) Table 195. South America General Medicines Revenue by Country (2021-2026) & (US$ Million) Table 196. South America General Medicines Revenue by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa General Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 198. Middle East and Africa General Medicines Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa General Medicines Sales by Country (2027-2032) & (K Units) Table 200. Middle East and Africa General Medicines Revenue by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa General Medicines Revenue by Country (2027-2032) & (US$ Million) Table 202. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 203. Global General Medicines Sales by Type (2027-2032) & (K Units) Table 204. Global General Medicines Sales Market Share by Type (2021-2026) Table 205. Global General Medicines Sales Market Share by Type (2027-2032) Table 206. Global General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 207. Global General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 208. Global General Medicines Revenue Market Share by Type (2021-2026) Table 209. Global General Medicines Revenue Market Share by Type (2027-2032) Table 210. Global General Medicines Price by Type (2021-2026) & (US$/Unit) Table 211. Global General Medicines Price by Type (2027-2032) & (US$/Unit) Table 212. Global General Medicines Sales by Application (2021-2026) & (K Units) Table 213. Global General Medicines Sales by Application (2027-2032) & (K Units) Table 214. Global General Medicines Sales Market Share by Application (2021-2026) Table 215. Global General Medicines Sales Market Share by Application (2027-2032) Table 216. Global General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 217. Global General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 218. Global General Medicines Revenue Market Share by Application (2021-2026) Table 219. Global General Medicines Revenue Market Share by Application (2027-2032) Table 220. Global General Medicines Price by Application (2021-2026) & (US$/Unit) Table 221. Global General Medicines Price by Application (2027-2032) & (US$/Unit) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. General Medicines Distributors List Table 225. General Medicines Customers List Table 226. General Medicines Industry Trends Table 227. General Medicines Industry Drivers Table 228. General Medicines Industry Restraints Table 229. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. General Medicines Product Image Figure 5. Global General Medicines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global General Medicines Market Size (2021-2032) & (US$ Million) Figure 7. Global General Medicines Sales (2021-2032) & (K Units) Figure 8. Global General Medicines Average Price (US$/Unit) & (2021-2032) Figure 9. Over-the-Counter (OTC) Product Image Figure 10. Prescription (Rx) Product Image Figure 11. Antihypertensives Product Image Figure 12. Antibiotics Product Image Figure 13. Antidiabetic Drugs Product Image Figure 14. Antipyretics Product Image Figure 15. Analgesics Product Image Figure 16. Others Product Image Figure 17. Global General Medicines Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of General Medicines, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global General Medicines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global General Medicines Sales by Region in 2025 Figure 23. Global General Medicines Revenue by Region in 2025 Figure 24. North America General Medicines Market Size by Country in 2025 Figure 25. North America General Medicines Sales Market Share by Country (2021-2032) Figure 26. North America General Medicines Revenue Market Share by Country (2021-2032) Figure 27. United States General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe General Medicines Market Size by Country in 2025 Figure 30. Europe General Medicines Sales Market Share by Country (2021-2032) Figure 31. Europe General Medicines Revenue Market Share by Country (2021-2032) Figure 32. Germany General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific General Medicines Market Size by Country in 2025 Figure 38. Asia Pacific General Medicines Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific General Medicines Revenue Market Share by Country (2021-2032) Figure 40. China General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America General Medicines Market Size by Country in 2025 Figure 49. South America General Medicines Sales Market Share by Country (2021-2032) Figure 50. South America General Medicines Revenue Market Share by Country (2021-2032) Figure 51. Mexico General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa General Medicines Market Size by Country in 2025 Figure 55. Middle East and Africa General Medicines Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa General Medicines Revenue Market Share by Country (2021-2032) Figure 57. Turkey General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE General Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global General Medicines Sales Market Share by Type (2021-2032) Figure 61. Global General Medicines Revenue Market Share by Type (2021-2032) Figure 62. Global General Medicines Price (US$/Unit) by Type (2021-2032) Figure 63. Global General Medicines Sales Market Share by Application (2021-2032) Figure 64. Global General Medicines Revenue Market Share by Application (2021-2032) Figure 65. Global General Medicines Price (US$/Unit) by Application (2021-2032) Figure 66. General Medicines Value Chain Figure 67. General Medicines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. General Medicines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Over-the-Counter (OTC)
  • Prescription (Rx)
Applications
  • Antihypertensives
  • Antibiotics
  • Antidiabetic Drugs
  • Antipyretics
  • Analgesics
  • Others
Companies covered
  • Sun Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Zoetis
  • Vertex Pharmaceuticals
  • Takeda Pharmaceutical
  • Seagen
  • Regeneron Pharmaceuticals
  • Novo Nordisk
  • Moderna
  • Lonza
  • Horizon Therapeutics
  • GlaxoSmithKline
  • Gilead Sciences
  • Daiichi Sankyō
  • CVS Health
  • Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Biogen
  • Argenx

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global General Medicines Market Size (2021-2032)
  4. 2.2.2 Global General Medicines Sales (2021-2032)
  5. 2.2.3 Global General Medicines Market Average Price (2021-2032)
  6. 2.3 General Medicines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Over-the-Counter (OTC)
  9. 2.3.3 Prescription (Rx)
  10. 2.4 General Medicines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Antihypertensives
  13. 2.4.3 Antibiotics
  14. 2.4.4 Antidiabetic Drugs
  15. 2.4.5 Antipyretics
  16. 2.4.6 Analgesics
  17. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global General Medicines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global General Medicines Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global General Medicines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global General Medicines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global General Medicines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of General Medicines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of General Medicines, Product Type & Application
  8. 3.8 Global Manufacturers of General Medicines, Established Date
  9. 3.9 Global General Medicines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sun Pharmaceutical
  2. 4.1.1 Sun Pharmaceutical Company Information
  3. 4.1.2 Sun Pharmaceutical Business Overview
  4. 4.1.3 Sun Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sun Pharmaceutical General Medicines Product Portfolio
  6. 4.1.5 Sun Pharmaceutical Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi General Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi General Medicines Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Johnson & Johnson
  14. 4.3.1 Johnson & Johnson Company Information
  15. 4.3.2 Johnson & Johnson Business Overview
  16. 4.3.3 Johnson & Johnson General Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Johnson & Johnson General Medicines Product Portfolio
  18. 4.3.5 Johnson & Johnson Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis General Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis General Medicines Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck General Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck General Medicines Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 Roche
  32. 4.6.1 Roche Company Information
  33. 4.6.2 Roche Business Overview
  34. 4.6.3 Roche General Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Roche General Medicines Product Portfolio
  36. 4.6.5 Roche Recent Developments
  37. 4.7 Eli Lilly
  38. 4.7.1 Eli Lilly Company Information
  39. 4.7.2 Eli Lilly Business Overview
  40. 4.7.3 Eli Lilly General Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Eli Lilly General Medicines Product Portfolio
  42. 4.7.5 Eli Lilly Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer General Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer General Medicines Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 Jiangsu Hengrui Medicine
  50. 4.9.1 Jiangsu Hengrui Medicine Company Information
  51. 4.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 4.9.3 Jiangsu Hengrui Medicine General Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiangsu Hengrui Medicine General Medicines Product Portfolio
  54. 4.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 4.10 Bayer
  56. 4.10.1 Bayer Company Information
  57. 4.10.2 Bayer Business Overview
  58. 4.10.3 Bayer General Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bayer General Medicines Product Portfolio
  60. 4.10.5 Bayer Recent Developments
  61. 4.11 Amgen
  62. 4.11.1 Amgen Company Information
  63. 4.11.2 Amgen Business Overview
  64. 4.11.3 Amgen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Amgen General Medicines Product Portfolio
  66. 4.11.5 Amgen Recent Developments
  67. 4.12 AbbVie
  68. 4.12.1 AbbVie Company Information
  69. 4.12.2 AbbVie Business Overview
  70. 4.12.3 AbbVie General Medicines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AbbVie General Medicines Product Portfolio
  72. 4.12.5 AbbVie Recent Developments
  73. 4.13 AstraZeneca
  74. 4.13.1 AstraZeneca Company Information
  75. 4.13.2 AstraZeneca Business Overview
  76. 4.13.3 AstraZeneca General Medicines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AstraZeneca General Medicines Product Portfolio
  78. 4.13.5 AstraZeneca Recent Developments
  79. 4.14 Zoetis
  80. 4.14.1 Zoetis Company Information
  81. 4.14.2 Zoetis Business Overview
  82. 4.14.3 Zoetis General Medicines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Zoetis General Medicines Product Portfolio
  84. 4.14.5 Zoetis Recent Developments
  85. 4.15 Vertex Pharmaceuticals
  86. 4.15.1 Vertex Pharmaceuticals Company Information
  87. 4.15.2 Vertex Pharmaceuticals Business Overview
  88. 4.15.3 Vertex Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Vertex Pharmaceuticals General Medicines Product Portfolio
  90. 4.15.5 Vertex Pharmaceuticals Recent Developments
  91. 4.16 Takeda Pharmaceutical
  92. 4.16.1 Takeda Pharmaceutical Company Information
  93. 4.16.2 Takeda Pharmaceutical Business Overview
  94. 4.16.3 Takeda Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Takeda Pharmaceutical General Medicines Product Portfolio
  96. 4.16.5 Takeda Pharmaceutical Recent Developments
  97. 4.17 Seagen
  98. 4.17.1 Seagen Company Information
  99. 4.17.2 Seagen Business Overview
  100. 4.17.3 Seagen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Seagen General Medicines Product Portfolio
  102. 4.17.5 Seagen Recent Developments
  103. 4.18 Regeneron Pharmaceuticals
  104. 4.18.1 Regeneron Pharmaceuticals Company Information
  105. 4.18.2 Regeneron Pharmaceuticals Business Overview
  106. 4.18.3 Regeneron Pharmaceuticals General Medicines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Regeneron Pharmaceuticals General Medicines Product Portfolio
  108. 4.18.5 Regeneron Pharmaceuticals Recent Developments
  109. 4.19 Novo Nordisk
  110. 4.19.1 Novo Nordisk Company Information
  111. 4.19.2 Novo Nordisk Business Overview
  112. 4.19.3 Novo Nordisk General Medicines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Novo Nordisk General Medicines Product Portfolio
  114. 4.19.5 Novo Nordisk Recent Developments
  115. 4.20 Moderna
  116. 4.20.1 Moderna Company Information
  117. 4.20.2 Moderna Business Overview
  118. 4.20.3 Moderna General Medicines Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Moderna General Medicines Product Portfolio
  120. 4.20.5 Moderna Recent Developments
  121. 4.21 Lonza
  122. 4.21.1 Lonza Company Information
  123. 4.21.2 Lonza Business Overview
  124. 4.21.3 Lonza General Medicines Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Lonza General Medicines Product Portfolio
  126. 4.21.5 Lonza Recent Developments
  127. 4.22 Horizon Therapeutics
  128. 4.22.1 Horizon Therapeutics Company Information
  129. 4.22.2 Horizon Therapeutics Business Overview
  130. 4.22.3 Horizon Therapeutics General Medicines Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Horizon Therapeutics General Medicines Product Portfolio
  132. 4.22.5 Horizon Therapeutics Recent Developments
  133. 4.23 GlaxoSmithKline
  134. 4.23.1 GlaxoSmithKline Company Information
  135. 4.23.2 GlaxoSmithKline Business Overview
  136. 4.23.3 GlaxoSmithKline General Medicines Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 GlaxoSmithKline General Medicines Product Portfolio
  138. 4.23.5 GlaxoSmithKline Recent Developments
  139. 4.24 Gilead Sciences
  140. 4.24.1 Gilead Sciences Company Information
  141. 4.24.2 Gilead Sciences Business Overview
  142. 4.24.3 Gilead Sciences General Medicines Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Gilead Sciences General Medicines Product Portfolio
  144. 4.24.5 Gilead Sciences Recent Developments
  145. 4.25 Daiichi Sankyō
  146. 4.25.1 Daiichi Sankyō Company Information
  147. 4.25.2 Daiichi Sankyō Business Overview
  148. 4.25.3 Daiichi Sankyō General Medicines Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Daiichi Sankyō General Medicines Product Portfolio
  150. 4.25.5 Daiichi Sankyō Recent Developments
  151. 4.26 CVS Health
  152. 4.26.1 CVS Health Company Information
  153. 4.26.2 CVS Health Business Overview
  154. 4.26.3 CVS Health General Medicines Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 CVS Health General Medicines Product Portfolio
  156. 4.26.5 CVS Health Recent Developments
  157. 4.27 Chugai Pharmaceutical
  158. 4.27.1 Chugai Pharmaceutical Company Information
  159. 4.27.2 Chugai Pharmaceutical Business Overview
  160. 4.27.3 Chugai Pharmaceutical General Medicines Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Chugai Pharmaceutical General Medicines Product Portfolio
  162. 4.27.5 Chugai Pharmaceutical Recent Developments
  163. 4.28 Bristol-Myers Squibb
  164. 4.28.1 Bristol-Myers Squibb Company Information
  165. 4.28.2 Bristol-Myers Squibb Business Overview
  166. 4.28.3 Bristol-Myers Squibb General Medicines Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 Bristol-Myers Squibb General Medicines Product Portfolio
  168. 4.28.5 Bristol-Myers Squibb Recent Developments
  169. 4.29 Biogen
  170. 4.29.1 Biogen Company Information
  171. 4.29.2 Biogen Business Overview
  172. 4.29.3 Biogen General Medicines Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 Biogen General Medicines Product Portfolio
  174. 4.29.5 Biogen Recent Developments
  175. 4.30 Argenx
  176. 4.30.1 Argenx Company Information
  177. 4.30.2 Argenx Business Overview
  178. 4.30.3 Argenx General Medicines Sales, Revenue and Gross Margin (2021-2026)
  179. 4.30.4 Argenx General Medicines Product Portfolio
  180. 4.30.5 Argenx Recent Developments
5 Global General Medicines Market Scenario by Region
  1. 5.1 Global General Medicines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global General Medicines Sales by Region: 2021-2032
  3. 5.2.1 Global General Medicines Sales by Region: 2021-2026
  4. 5.2.2 Global General Medicines Sales by Region: 2027-2032
  5. 5.3 Global General Medicines Revenue by Region: 2021-2032
  6. 5.3.1 Global General Medicines Revenue by Region: 2021-2026
  7. 5.3.2 Global General Medicines Revenue by Region: 2027-2032
  8. 5.4 North America General Medicines Market Facts & Figures by Country
  9. 5.4.1 North America General Medicines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America General Medicines Sales by Country (2021-2032)
  11. 5.4.3 North America General Medicines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe General Medicines Market Facts & Figures by Country
  15. 5.5.1 Europe General Medicines Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe General Medicines Sales by Country (2021-2032)
  17. 5.5.3 Europe General Medicines Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific General Medicines Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific General Medicines Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific General Medicines Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific General Medicines Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America General Medicines Market Facts & Figures by Country
  35. 5.7.1 South America General Medicines Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America General Medicines Sales by Country (2021-2032)
  37. 5.7.3 South America General Medicines Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa General Medicines Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa General Medicines Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa General Medicines Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa General Medicines Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global General Medicines Sales by Type (2021-2032)
  2. 6.1.1 Global General Medicines Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global General Medicines Sales Market Share by Type (2021-2032)
  4. 6.2 Global General Medicines Revenue by Type (2021-2032)
  5. 6.2.1 Global General Medicines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global General Medicines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global General Medicines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global General Medicines Sales by Application (2021-2032)
  2. 7.1.1 Global General Medicines Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global General Medicines Sales Market Share by Application (2021-2032)
  4. 7.2 Global General Medicines Revenue by Application (2021-2032)
  5. 7.2.1 Global General Medicines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global General Medicines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global General Medicines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 General Medicines Value Chain Analysis
  2. 8.1.1 General Medicines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 General Medicines Production Mode & Process
  5. 8.2 General Medicines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 General Medicines Distributors
  8. 8.2.3 General Medicines Customers
9 Global General Medicines Analyzing Market Dynamics
  1. 9.1 General Medicines Industry Trends
  2. 9.2 General Medicines Industry Drivers
  3. 9.3 General Medicines Industry Opportunities and Challenges
  4. 9.4 General Medicines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst